Linezolid plus standard care for staph bloodstream infections
Treatments studied
Part of Infections clinical trials.
This trial tests whether adding linezolid, an antibiotic that stops bacteria from making proteins, to usual care works better for treating Staphylococcus aureus bloodstream infections. You may be eligible if you have this infection and are hospitalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a Staphylococcus aureus (staph) infection confirmed in a blood test
- You are currently in the hospital at a participating center
- You are 18 years or older
- You can give written consent, or a doctor can include you under emergency consent rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antibiotics, cloxacillin and benzylpenicillin, to see which works better for patients with a bloodstream infection caused by a specific type of staph bacteria that responds well to penicillin. It may help guide more effective treatment.
This Phase 2 study tests whether continuous IV antibiotics plus “drug level monitoring” (TDM) works better than the usual treatment for complicated Staph aureus infections. It may help ensure the antibiotic dose stays in an effective range while you’re being treated.
This trial tests whether switching from IV antibiotics to oral antibiotics after 3–7 days is safe and effective for people with uncomplicated Staphylococcus aureus bloodstream infections. It may help you avoid a longer hospital stay and reduce IV-related complications.
This trial tests whether a personalized dosing approach for linezolid (an antibiotic) works better than the standard dose. It is for adults with pneumonia or skin/soft tissue infections who have just started or are about to start linezolid.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
Hear when a new Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.